Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms.

Prospective work based on the distribution of a dedicated questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myeloproliferative Disorder Bone Marrow Diseases Hematologic Diseases Hemic and Lymphatic Diseases Myeloproliferative Disorders

Sex eligibility

All sexes

Study type

Observational

About this study

Patients with myeloproliferative neoplasms identified and followed in our Institution (Brest University Hospital). Patients could be followed for polycythemia vera or essential thrombocythemia or myelofibrosis.

Distribution of the questionnaire to each patients with myeloproliferative neoplasms (treated or not) suffering from aquagenic pruritus.

Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients followed with myeloproliferative neoplasms
suffering from aquagenic pruritus

Exclusion criteria

Unable to fulfil the questionnaire
No written informed consent

Treatment and study plan

Primary outcomes

Intensity of the pruritus

Time frame: 15 days

Analogic Visual Scale, from 0 to 10, Worse if >6

Secondary outcomes

Duration of the pruritus

Time frame: 15 days

Timing expresses in minutes

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Aquagenic Pruritus Among Patients With Myeloproliferative Syndromes (in English) Prurit Aquagénique Dans Les SYndromes MyéloProLifEratifs (in French)

Acronym: PASYMPLE

Important dates

Study start: 2013
Primary completion: 2013
Study completion: 2013
First posted: Sep 28, 2018
Registry last updated: Jul 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed